Company type | Private |
---|---|
Industry | Pharmaceutical |
Founded | 1995 |
Founder | Muhammad Jawed Akhai |
Headquarters | Karachi, Pakistan |
Area served | Asia, Middle East, Europe, Africa |
Products | ADVIT-D, BUSCOPAN PLUS, CONCOR, GLUCOPHAGE, INFEXIN CAPS, KLARIBACT, MERCIP, NEUROBION, POLYBION, ROZANTO, SANGOBION, TIXOMER, VONOSPIRE, WINTOGENO |
Revenue | Rs. 5000 crore (US$170 million) (2021) [1] |
Number of employees | 1,000+ [2] |
Subsidiaries | Martin Dow Limited Martin Dow Marker Ltd. Martin Dow Specialities (Pvt.) Ltd. Martin Dow Pharmaceuticals (France) |
Website | martindow |
Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi. It was founded in 1995 [3] [4] and has six manufacturing facilities in Pakistan [5] and one in France. [6]
Martin Dow was founded in 1995 and began operations in 2000 with a small manufacturing facility in Lahore. [7]
In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan. [8]
In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum. [9] In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company. [10]
In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd. [11] [12] [13]
In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France. [14] [15] In March 2017, the French President Francois Hollande inaugurated Martin Dow Pharma's Meymac Plant in France. [16] [17] The plant of V2Pharm in Gien, France was also taken over by Martin Dow. [18]
In 2020, Martin Dow was awarded for excellent performance in fire safety and protection by the Sindh local government minister. [19]
In 2016, the National Accountability Bureau (NAB) arrested two directors of Martin Dow because it wrongfully derived financial benefits on the basis of illegal price increase. [20] [21] [22]
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).
Lucky Core Industries Limited, formerly known as ICI Pakistan, is a Pakistani conglomerate company headquartered in Karachi. It manufactures polyester, pharmaceutical, agrochemical, soda ash, and veterinary medicine.
GlaxoSmithKline (GSK) Pakistan is a Pakistani pharmaceutical company which is a subsidiary of British company GSK. It is the largest pharmaceutical company in Pakistan.
A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Granules India Limited is an Indian multinational pharmaceutical manufacturing company based in Hyderabad. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited also operates in the contract research and manufacturing (CRAM) segment.
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of APIs locally produced. Pakistani pharmaceutical companies are engaged in importing raw materials, compounding APIs with excipients, coating of pills, and fill-finish activities. The industry is regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
Curia is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, Curia operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. Curia has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Company, Takeda, Genentech, Bristol-Myers Squibb Co. and GE.
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden.
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
Catalent, Inc., a subsidiary of Novo Holdings A/S since 2024, is a multinational corporation headquartered in Somerset, New Jersey. It is a provider of drug delivery technologies, drug development, drug manufacturing, biologics, gene therapy, and consumer health products. It has over 50 facilities on 4 continents and has supported more than half the products approved by the Food and Drug Administration in the last 10 years. Annually, it produces 70 billion doses for 8,000 products. The company's major customers include Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Haleon, Novo Nordisk, Moderna, Pfizer, and Sarepta Therapeutics.
Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.
Cheplapharm Arzneimittel GmbH, headquartered in Greifswald, is a German pharmaceutical company that markets branded drugs, medical products, supplements and cosmetics.
Martin Dow was established in 1995 initially as a pharmaceutical marketing company in Karachi (Pakistan)
With the acquisition of Merck Pakistan, Martin Dow will have six manufacturing facilities in the country.
A Pakistani Pharmaceutical company, Martin Dow has acquired a pharmaceutical manufacturing facility in Meymac, France. The facility was earlier owned by the renowned pharmaceutical firm Bristol-Myers Squibb.